NCT00686140View on ClinicalTrials.gov

A Double-blind and Randomized Trial of Celecoxib Added to Risperidone in Treatment-naive First-episode Schizophrenia

NACompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

December 31, 2007

Study Completion Date

March 31, 2008

Conditions
Schizophrenia
Interventions
DRUG

celecoxib

400mg/day, twice a day, 12 weeks

DRUG

Placebo

twice a day, 12 weeks

Trial Locations (1)

100096

Beijing HuiLongGuan Hospital, Beijing

All Listed Sponsors
collaborator

Stanley Medical Research Institute

OTHER

lead

Beijing HuiLongGuan Hospital

OTHER

NCT00686140 - A Double-blind and Randomized Trial of Celecoxib Added to Risperidone in Treatment-naive First-episode Schizophrenia | Biotech Hunter | Biotech Hunter